Suggested Usage : Ingredients : Purified Water, L-Carnitine, Citric Acid, Natural and Artificial Flavours, Potassium Sorbate, Sodium Benzonate, Sucralose, Calcium D-Pantothenate
10.1081/JAS-200038447
2 The findings from the OASIS 4 trial, published in the New England Journal of Medicine in September 2025, led the FDA to approve the Wegovy pill in December 2025, making it the first oral GLP-1 medication approved specifically for weight loss
Weeks 2 through 4: settling in Continue at 0.25 mg weekly
Sustained Weight Maintenance: The SCALE Maintenance trial demonstrated that 81.4% of Liraglutide-treated patients maintained their initial 5% weight loss, compared to only 48.9% of placebo-treated patients , proving its effectiveness for long-term weight management rather than just initial loss